Harvard Management Company: Stock Portfolio, Performance and Latest Trades
13F portfolio value
$4.3B
19 holdings at Q2 2026
Get an email when Harvard Management Company files a new 13F report
Free, no account needed. Unsubscribe with one click.
Harvard Management Company's portfolio
As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026
| Company | Share of portfolio | Average buy price | Return | Current price | Last quarter |
|---|---|---|---|---|---|
| 51.8% | $170.86 | −6.0% | $160.57 | New | |
| 8.20% | $312.54 | +46.5% | $457.99 | Added +6.6% | |
| 5.61% | $235.36 | −28.7% | $167.92 | New | |
Amazon.com Inc.AMZN | 5.49% | $213.08 | +19.2% | $254.06 | Added +37% |
Alphabet Inc.GOOGL | 3.87% | $166.45 | +109% | $348.29 | Reduced −25% |
Nvidia Corp.NVDA | 3.70% | $129.92 | +77.4% | $230.48 | Added +5.9% |
| 3.51% | $84.89 | −8.5% | $77.66 | New | |
Microsoft Corp.MSFT | 3.43% | $417.95 | +25.0% | $522.61 | Reduced −24% |
Broadcom Inc.AVGO | 3.00% | $304.44 | +18.3% | $360.14 | Reduced −29% |
| 2.83% | $444.37 | +62.2% | $720.89 | Added +10% | |
| 2.38% | $62.53 | −26.0% | $46.26 | No change | |
Netflix Inc.NFLX | 1.85% | $88.07 | −18.7% | $71.57 | New |
| 1.73% | $538.22 | — | — | Added +1087% | |
| 0.86% | $36.11 | −61.8% | $13.80 | New | |
| 0.55% | $892.05 | +17.5% | $1,048.60 | New | |
| 0.51% | $310.69 | +21.9% | $378.62 | Reduced −87% | |
| 0.44% | $12.21 | +14.6% | $13.99 | No change | |
| 0.15% | $176.99 | −56.3% | $77.28 | No change | |
| 0.04% | $0.77 | −27.3% | $0.56 | No change |
Harvard Management Company's buys and sells
| Company | Action | Shares change | Value now |
|---|---|---|---|
Alphabet Inc.GOOGL | Reduced −28% | −672,665 | $227.5M |
| Reduced −16% | −177,411 | $287.8M | |
Maplebear Inc.CART | New | +519,838 | $15.4M |
Eqrx Inc.26886C107 | Sold out | −3,853,367 | — |
| Sold out | −882,129 | — | |
| Reduced −8.7% | −16,143 | $7M | |
| Sold out | −314,762 | — | |
| Sold out | −233,186 | — | |
Generation Bio Co.37148K100 | Sold out | −510,354 | — |
| Reduced −54% | −252,373 | $837K | |
Kinnate Biopharma Inc.49705R105 | Sold out | −462,418 | — |
Decibel Therapeutics Inc.24343R106 | Sold out | −326,029 | — |
| Sold out | −341,972 | — | |
Praxis Precision Medicines I74006W108 | Sold out | −692,617 | — |
Pardes Biosciences Inc.69945Q105 | Sold out | −400,000 | — |
| Sold out | −8,452 | — | |
Magenta Therapeutics Inc.55910K108 | Sold out | −332,610 | — |
Harvard Management Company's portfolio by sector
Share of the stock portfolio at Q2 2026.
| Sector | Share |
|---|---|
| Technology | 76% |
| Communication Services | 8.6% |
| Consumer Discretionary | 7.2% |
| Financials | 6.4% |
| Utilities | 0.9% |
| Health Care | 0.4% |
| Materials | 0.0% |
Portfolio performance: Harvard Management Company vs. benchmarks
Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.
- You, copying after each 13F filing – estimated value
- S&P 500
- Nasdaq-100
| Total return | Per year | |
|---|---|---|
| You, copying after each 13F filing – estimated value | +97.2% | +14.5% |
| S&P 500 | +89.0% | +13.6% |
| Nasdaq-100 | +113.3% | +16.4% |
Prices were available for 80% of the portfolio value on average; the rest is left out of the return.
Harvard Management Company's most traded stocks
Quarters with a buy or a sell, all reports since Q2 2013.
| Company | Quarters bought | Quarters sold |
|---|---|---|
| 29 | 73 | |
| 19 | 19 | |
| 18 | 18 | |
| 11 | 19 | |
| 13 | 16 | |
| 14 | 15 | |
Alphabet Inc.GOOGL | 14 | 12 |
| 11 | 14 | |
| 5 | 19 | |
Apple Inc.AAPL | 8 | 12 |
| 11 | 8 | |
| 9 | 8 | |
| 12 | 5 | |
Microsoft Corp.MSFT | 7 | 7 |
| 7 | 7 |